Wise切口两期乳房缩小再造:脱细胞真皮基质与否的结果比较
一期后总体并发症发生率两组相似(ADM组32.4% vs 非ADM组35.4%,p=0.684),但ADM组轻微感染率显著更高(16.2% vs 6.3%,p=0.040);二期后并发症发生率亦相似(16.2% vs 13.5%,p=0.638)。最终随访445.2天。结论提示去表皮真皮瓣可提供足够假体支撑,无需ADM。
要点
- 一期后总体并发症发生率ADM组与非ADM组相似(32.4% vs 35.4%,p=0.684)。
- ADM组轻微感染率显著高于非ADM组(16.2% vs 6.3%,p=0.040)。
- 去表皮真皮瓣可替代ADM提供假体支撑,避免ADM相关感染风险。
核心结论
- 两期乳房缩小再造中,使用与不使用ADM的总体并发症发生率相似。
- 使用ADM时扩张器置入后轻微感染率更高。
- 去表皮真皮瓣可提供足够假体支撑,无需ADM。
研究设计与样本
- 按是否使用ADM分为两组:ADM组68侧,非ADM组96侧。
主要发现
- 一期后总体并发症发生率:ADM组32.4%,非ADM组35.4%,p=0.684。
- 一期后轻微感染率:ADM组16.2%,非ADM组6.3%,p=0.040。
- 二期后并发症发生率:ADM组16.2%,非ADM组13.5%,p=0.638。
- 最终随访时间445.2天。
临床怎么用
- 对希望行缩小再造的患者,可考虑使用去表皮真皮瓣替代ADM以支撑假体。
- 使用ADM时需警惕扩张器置入后轻微感染风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aesthetic results in breast reconstruction for ptotic/obese breasts may be improved when using Wise-pattern closures compared with nipple-sparing mastectomies. In two-stage reconstruction, acellular dermal matrix is commonly used to support the prosthesis. This study tests the efficacy of an alternate technique that uses deepithelialized excess breast skin in lieu of acellular dermal matrix. To better understand whether acellular dermal matrix is necessary, the authors compared postoperative outcomes from reduction-reconstructions that used matrix to those that did not. METHODS: The authors retrospectively reviewed the outcomes of patients who underwent staged breast reconstruction following Wise-pattern closures between September of 2016 and October of 2019. Two cohorts were created based on whether acellular dermal matrix was used. Charts were reviewed for incidence of postoperative complications. RESULTS: A total of 164 breasts were reconstructed in 85 female patients. The acellular dermal matrix cohort consisted of 68 breasts, whereas the non-acellular dermal matrix cohort included 96 breasts. After the first stage, the incidence of one or more complications was similar between cohorts (acellular dermal matrix, 32.4 percent; nonmatrix, 35.4 percent; p = 0.684). Minor infection rates were significantly higher in reconstructions using acellular dermal matrix (16.2 percent versus 6.3 percent; p = 0.040). After the second stage, the complication incidence was also similar between cohorts (acellular dermal matrix, 16.2 percent; nonmatrix, 13.5 percent; p = 0.638). Final follow-up time was 445.2 days. CONCLUSIONS: Overall complication rates following both stages of reconstruction were similar with and without acellular dermal matrix. When acellular dermal matrix was used, minor infection rates were higher following expander placement. In patients desiring a reduction-reconstruction, the authors find the deepithelialized dermal flap provides ample prosthesis support, without the need for acellular dermal matrix. . CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Patel AA, Kayaleh H, Sala LA, et al. Comparing Outcomes of Wise-Pattern, Two-Stage Breast Reduction-Reconstruction with and without Acellular Dermal Matrix. Plast Reconstr Surg. 2021. PMID: 34432681. doi:10.1097/PRS.0000000000008298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。